Serum butyrylcholinesterase predicts survival after extracorporeal membrane oxygenation after cardiovascular surgery

Critical Care

Volumn 18, Issue 1, 2014, Pages

  Distelmaier, Klaus ^a,b   Winter, Max Paul ^a   Rützler, Kurt ^a,c   Heinz, Gottfried ^a   Lang, Irene M ^a   Maurer, Gerald ^a   Koinig, Herbert ^d   Steinlechner, Barbara ^a   Niessner, Alexander ^a   Goliasch, Georg ^a,e  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Mayo Clinic   (United States)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d Landesklinikum Krems ^*  (Austria)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE;

AGED; BLOOD; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SURGERY; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; PROCEDURES; PROGNOSIS; RISK FACTOR; SURVIVAL RATE;

AGED; BUTYRYLCHOLINESTERASE; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SURGICAL PROCEDURES; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 84893198588     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13711     Document Type: Article

References (27)

1. Bartlett RH, Roloff DW, Custer JR, Younger JG, Hirschl RB. Extracorporeal life support: the University of Michigan experience. JAMA 2000, 283:904-908. 10.1001/jama.283.7.904, 10685715.
2. Combes A, Leprince P, Luyt CE, Bonnet N, Trouillet JL, Leger P, Pavie A, Chastre J. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 2008, 36:1404-1411. 10.1097/CCM.0b013e31816f7cf7, 18434909.
3. Calderon-Margalit R, Adler B, Abramson JH, Gofin J, Kark JD. Butyrylcholinesterase activity, cardiovascular risk factors, and mortality in middle-aged and elderly men and women in Jerusalem. Clin Chem 2006, 52:845-852. 10.1373/clinchem.2005.059857, 16527886.
4. Goliasch G, Haschemi A, Marculescu R, Endler G, Maurer G, Wagner O, Huber K, Mannhalter C, Niessner A. Butyrylcholinesterase activity predicts long-term survival in patients with coronary artery disease. Clin Chem 2012, 58:1055-1058. 10.1373/clinchem.2011.175984, 22294734.
5. Stedman E, Easson LH. Choline-esterase: an enzyme present in the blood-serum of the horse. Biochem J 1932, 26:2056-2066. 1261137, 16745037.
6. Darvesh S, Hopkins DA, Geula C. Neurobiology of butyrylcholinesterase. Nat Rev Neurosci 2003, 4:131-138. 10.1038/nrn1035, 12563284.
7. Bretlau C, Kryspin Soerensen M, Zimling Vedersoe AL, Simon Rasmussen L, Ring Gatke M. Response to succinylcholine in patients carrying the k-variant of the butyrylcholinesterase gene. Anesth Analg 2013, 116:596-601. 10.1213/ANE.0b013e318280a3f3, 23400986.
8. Gatke MR, Bundgaard JR, Viby-Mogensen J. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia. Pharmacogenet Genom 2007, 17:995-999.
9. Gatke MR, Viby-Mogensen J, Ostergaard D, Bundgaard JR. Response to mivacurium in patients carrying the k variant in the butyrylcholinesterase gene. Anesthesiology 2005, 102:503-508. 10.1097/00000542-200503000-00005, 15731585.
10. Distelmaier K, Niessner A, Haider D, Lang IM, Heinz G, Maurer G, Koinig H, Steinlechner B, Goliasch G. Long-term mortality in patients with chronic obstructive pulmonary disease following extracorporeal membrane oxygenation for cardiac assist after cardiovascular surgery. Intensive Care Med 2013, 39:1444-1451. 10.1007/s00134-013-2931-y, 23612760.
11. den Blaauwen DH, Poppe WA, Tritschler W. Cholinesterase (EC 3.1.1.8) with butyrylthiocholine-iodide as substrate: references depending on age and sex with special reference to hormonal effects and pregnancy. J Clin Chem Clin Biochem 1983, 21:381-386.
12. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963. 10.1001/jama.1993.03510240069035, 8254858.
13. Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E, Cortina J, David M, Faichney A, Gabrielle F, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999, 15:816-822. discussion 822-813, 10.1016/S1010-7940(99)00106-2, 10431864.
14. Rastan AJ, Dege A, Mohr M, Doll N, Falk V, Walther T, Mohr FW. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg 2010, 139:302-311. 311 e301, 10.1016/j.jtcvs.2009.10.043, 20106393.
15. Smedira NG, Blackstone EH. Postcardiotomy mechanical support: risk factors and outcomes. Ann Thorac Surg 2001, 71:S60-S66. discussion S82-65, 10.1016/S0003-4975(00)02626-6, 11265868.
16. Wang JG, Han J, Jia YX, Zeng W, Hou XT, Meng X. Outcome of veno-arterial extracorporeal membrane oxygenation for patients undergoing valvular surgery. PLoS One 2013, 8:e63924. 10.1371/journal.pone.0063924, 3662767, 23717509.
17. Chang WW, Tsai FC, Tsai TY, Chang CH, Jenq CC, Chang MY, Tian YC, Hung CC, Fang JT, Yang CW, et al. Predictors of mortality in patients successfully weaned from extracorporeal membrane oxygenation. PLoS One 2012, 7:e42687. 10.1371/journal.pone.0042687, 3411657, 22870340.
18. Hubbard RE, O'Mahony MS, Calver BL, Woodhouse KW. Plasma esterases and inflammation in ageing and frailty. Eur J Clin Pharmacol 2008, 64:895-900. 10.1007/s00228-008-0499-1, 18506436.
19. Summerbell J, Wynne H, Hankey CR, Williams FM. The effect of age and frailty upon blood esterase activities and their response to dietary supplementation. Br J Clin Pharmacol 1993, 36:399-404. 10.1111/j.1365-2125.1993.tb00387.x, 1364611, 12959286.
20. Cerejeira J, Batista P, Nogueira V, Firmino H, Vaz-Serra A, Mukaetova-Ladinska EB. Low preoperative plasma cholinesterase activity as a risk marker of postoperative delirium in elderly patients. Age Ageing 2011, 40:621-626. 10.1093/ageing/afr053, 21576115.
21. Kemkes-Matthes B, Preissner KT, Langenscheidt F, Matthes KJ, Muller-Berghaus G. S protein/vitronectin in chronic liver diseases: correlations with serum cholinesterase, coagulation factor X and complement component C3. Eur J Haematol 1987, 39:161-165.
22. Ogunkeye OO, Roluga AI. Serum cholinesterase activity helps to distinguish between liver disease and non-liver disease aberration in liver function tests. Pathophysiology 2006, 13:91-93. 10.1016/j.pathophys.2006.01.002, 16530396.
23. Aubron C, Cheng AC, Pilcher D, Leong T, Magrin G, Cooper DJ, Scheinkestel C, Pellegrino V. Factors associated with outcomes of patients on extracorporeal membrane oxygenation support: a 5-year cohort study. Crit Care 2013, 17:R73. 10.1186/cc12681, 23594433.
24. Mc IRB, Timpa JG, Kurundkar AR, Holt DW, Kelly DR, Hartman YE, Neel ML, Karnatak RK, Schelonka RL, Anantharamaiah GM, et al. Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine. Lab Invest 2010, 90:128-139. 10.1038/labinvest.2009.119, 2799549, 19901912.
25. Masson P. A naturally occurring molecular form of human plasma cholinesterase is an albumin conjugate. Biochim Biophys Acta 1989, 998:258-266. 10.1016/0167-4838(89)90282-3, 2553123.
26. Hsu PS, Chen JL, Hong GJ, Tsai YT, Lin CY, Lee CY, Chen YG, Tsai CS. Extracorporeal membrane oxygenation for refractory cardiogenic shock after cardiac surgery: predictors of early mortality and outcome from 51 adult patients. Eur J Cardiothorac Surg 2010, 37:328-333.
27. Slottosch I, Liakopoulos O, Kuhn E, Deppe AC, Scherner M, Madershahian N, Choi YH, Wahlers T. Outcomes after peripheral extracorporeal membrane oxygenation therapy for postcardiotomy cardiogenic shock: a single-center experience. J Surg Res 2013, 181:e47-e55. 10.1016/j.jss.2012.07.030, 22878151.